20.07.2021 | History

2 edition of DIGENE CORP. found in the catalog.


Labor Productivity Benchmarks and International Gap Analysis (Labor Productivity Series)

  • 2436 Want to read
  • 650 Currently reading

Published by Administrator in Icon Group International

  • United States
    • Subjects:
    • Icon Group International

      • Download DIGENE CORP. Book Epub or Pdf Free, DIGENE CORP., Online Books Download DIGENE CORP. Free, Book Free Reading DIGENE CORP. Online, You are free and without need to spend extra money (PDF, epub) format You can Download this book here. Click on the download link below to get DIGENE CORP. book in PDF or epub free.

      • nodata

        StatementIcon Group International
        PublishersIcon Group International
        LC ClassificationsApril 25, 2000
        The Physical Object
        Paginationxvi, 57 p. :
        Number of Pages59
        ID Numbers
        ISBN 100597325294

        nodata File Size: 6MB.

Share this book
You might also like

DIGENE CORP. by Icon Group International Download PDF EPUB FB2

[7] On October 18, 2002, Digene moved for leave to file an Amended Complaint, [8] DIGENE CORP. the court granted on December 10, 2002. [42] In Shure Brothers, Inc. DIGENE CORP. On December 27, 2002, Ventana filed a motion to compel arbitration, to the stay proceedings, and to dismiss the conspiracy claim in the Amended Complaint. In such event, once the Participant ceases to be a Director DIGENE CORP. the Company or its successor, all Stock Options held by such Participant that were exercisable on the date the Participant ceased to be a Director may be exercised by the Participant at any time during the three month period after the Participant ceases to be a Director.

77 C 1609, 198 U. From time to time, the Board may increase the size of the Committee and appoint additional members thereof, remove members with or without DIGENE CORP.

and appoint new members in substitution therefor, fill vacancies however caused and remove all members of the Committee. Product development activities are currently focused on improving and simplifying cervical specimen processing procedures and increasing Hybrid Capture 2 assay throughput, including a new batch preparation method for processing liquid-based cytology specimens for Hybrid Capture testing.

Court of Appeals for the Eleventh Circuit. 75 million to Georgetown in October 2005. 1 e relating to adjustment for changes in Common Stockthe maximum number of shares that may be issued under this Plan shall not exceed in the aggregate two million shares of Common Stock. The trial court held that plaintiff had not alleged sufficient facts to support those claims and, even if sufficient facts had been alleged, the patent laws preempted those claims.

The foregoing allegations of this amended complaint are incorporated by reference. h Restrictions on Requirement to Hold Common Stock after Exercise. Each Restricted Stock Unit Award shall be evidenced by, and subject to the terms of, a Restricted Stock Unit Agreement executed by the Company and the Participant. Alternatively, assuming the requirement exists, Digene maintains that they have sufficiently, "implicitly" plead "bad faith" on the part of Biochem.

Such Company records, absent manifest error, shall be binding on Employees. You may read and copy any reports, statements or other information filed or furnished by QIAGEN or Digene at the SEC's Public Reference Room at Station Place, 100 F Street, N.

Digene Stock Quote. DIGE

DIGENE CORP., 2001, Digene Corporation filed an action for patent infringement against Ventana Medical Systems, Inc. Biochem, through its statements and course of conduct set forth above, intentionally interfered with Digene's relationship or expectancy By reason of Biochem's intentional interference, Digene has suffered and will continue to suffer damages, including lost sales and profits, that Digene would have made but for Biochem's acts D.

Cytyc's product accounts for 93 percent of U. Under the Agreement with Georgetown, we were granted irrevocable, worldwide, exclusive, royalty-bearing licenses with the right to grant sublicenses under two Georgetown patents, as well as corresponding foreign patents and patent applications.

These forward-looking statements are not guarantees of the future as there are a number of meaningful factors DIGENE CORP. could cause the Company's actual results to vary materially from those indicated by such forward-looking statements.

Additionally, in regard to the second prong of the fourth element, Digene plainly alleges that both its products, and those advertised by Biochem are "sold and used in interstate commerce", in satisfaction of this element. Such shares may be authorized and unissued shares or authorized and issued shares that have been reacquired by the Company., 1429 3d Cir.